| Health / Medical Topics |
Lucatumumab
A fully human monoclonal antibody directed against the B-cell surface antigen CD40 with potential antineoplastic activity. Lucatumumab binds to and inhibits CD40, thereby inhibiting CD40 ligand-induced cell proliferation and triggering cell lysis via antibody-dependent cellular cytotoxicity (ADCC) in cells overexpressing CD40. CD40, an integral membrane protein found on the surface of B lymphocytes, is a member of the tumor necrosis factor receptor superfamily and is highly expressed in a number of B-cell malignancies. (NCI Thesaurus)
YOU MAY ALSO LIKE
An orally available thioxanthone-based DNA intercalator and inhibitor of the DNA repair enzyme apurinic-apyrimidinic endonuclease 1 (APEX1 or APE1), with anti-schistosomal and…
Luc Genes encode Luciferase, flavoprotein enzymes in certain marine crustaceans, fish, bacteria, and insects that catalyze bioluminescent oxidization of Luciferins to an…
A commercial combination preparation, by Bradley Pharmaceuticals, containing a mixture of polyethylene glycols, glycerol and caprylic/capric triglyceride with lubrication activity. Lubrin is…
Any of the commercial combination preparations, by Pfizer, containing humectants, emollients and emulsifiers with moisturizing activity. Lubriderm increases the skin's hydration and…
Lubricant excipient is a therapeutically inactive substance used to facilitate the release of stamped solid pharmaceutical dosage forms, e.g. tablets, out of…
An oily or slippery substance.
